Monthly Archives: September 2018

//September

MHRA Drug Safety Update – September 2018

Date issued: 25th September 2018 A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (vol 12, Issue 2, September 2018) has been published and includes articles on: Valproate Pregnancy Prevention Programme: actions required now from GPs, specialists, and dispensers; Xofigo▼ (radium-223-dichloride): new restrictions on use due to increased risk of fracture and...

By |September 25th, 2018|Lexpos News|Comments Off on MHRA Drug Safety Update – September 2018

Ask PSNC: Flu FAQs

The team at PSNC has received a number of queries on the NHS Flu Vaccination Service 2018/19. Below are some of the questions asked in recent weeks. Q. I have accidentally administered a quadrivalent influenza vaccine (QIV) to a patient aged 65 years instead of the adjuvanted trivalent influenza vaccine (aTIV); what should I do?...

By |September 25th, 2018|Lexpos News|Comments Off on Ask PSNC: Flu FAQs

Flu claim form and digital claiming guidance available from NHS BSA

The NHS Business Services Authority (NHS BSA) has published the claim form for the NHS Flu Vaccination Service 2018/19 as well as two guidance documents on how contractors can claim for payment electronically. This year contractors have the option of claiming payment for the Flu Vaccination Service either via the paper claim form or via...

By |September 25th, 2018|Lexpos News|Comments Off on Flu claim form and digital claiming guidance available from NHS BSA

September edition of CPN magazine now available

The September 2018 edition of PSNC’s Community Pharmacy News (CPN) is now available. This month’s CPN features: Don’t miss the latest digital developments and events; Brexit – representing pharmacy; CEO Blog; and Flu vaccination resources. View our CPN magazine online via the flipbook reader below or download the PDF copy. Please note, the colour PDF...

By |September 24th, 2018|Lexpos News|Comments Off on September edition of CPN magazine now available

MHRA Company-led recall Imatinib 400mg capsules (3×10) (Cipla EU)

Date issued: 21st September 2018 Cipla (EU) Limited has informed MHRA that there is an error on the Patient Information Leaflet (PIL) for the above product: the dosage information for the indication CML is incorrect Action Pharmacists are asked to remove the defective PIL from affected cartons before dispensing and provide a copy of the...

By |September 24th, 2018|Lexpos News|Comments Off on MHRA Company-led recall Imatinib 400mg capsules (3×10) (Cipla EU)